Physiomics Plc (LON:PYC – Get Free Report) shares fell 9.2% during trading on Wednesday . The company traded as low as GBX 0.95 ($0.01) and last traded at GBX 0.95 ($0.01). 1,137,122 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 7,175,730 shares. The stock had previously closed at GBX 1.05 ($0.01).
Physiomics Stock Down 9.5 %
The company has a market capitalization of £1.93 million, a P/E ratio of -13.83 and a beta of 1.69. The company has a 50-day moving average of GBX 0.82 and a two-hundred day moving average of GBX 0.73.
Insider Activity
In related news, insider Peter Sargent bought 459,090 shares of the company’s stock in a transaction on Thursday, November 7th. The shares were acquired at an average cost of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,730.03). Company insiders own 4.18% of the company’s stock.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Featured Stories
- Five stocks we like better than Physiomics
- Election Stocks: How Elections Affect the Stock Market
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Most Volatile Stocks, What Investors Need to Know
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Manufacturing Stocks Investing
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
